Research ArticleClinical Studies

A BRCA2 Mutation, 4088insA, in a Finnish Breast and Ovarian Cancer Family Associated with Favourable Clinical Course

JAANA M. HARTIKAINEN, ARTO MANNERMAA, SEPPO HEINONEN, VELI-MATTI KOSMA and VESA KATAJA
Anticancer Research November 2007, 27 (6C) 4295-4300;

Article Information

vol. 27 no. 6C 4295-4300
PubMed 
18214034
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 26, 2007
  • Revision received September 5, 2007
  • Accepted October 1, 2007
  • Published online November 1, 2007.
Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. JAANA M. HARTIKAINEN1,2,3,
  2. ARTO MANNERMAA1,3,
  3. SEPPO HEINONEN4,
  4. VELI-MATTI KOSMA1,3 and
  5. VESA KATAJA2
  1. 1Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Kuopio, FI-70211 Kuopio
  2. 2Department of Oncology, Kuopio University Hospital, FI-70211 Kuopio, Finland
  3. 3Department of Pathology, Kuopio University Hospital, FI-70211 Kuopio, Finland
  4. 4Department of Obstetrics and Gynaecology, Kuopio University Hospital, FI-70211 Kuopio, Finland
  1. Correspondence to: Jaana Hartikainen, Ph.D., Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland. Fax: +358 17 162753, Tel: +358 17 162754, e-mail: jaana.hartikainen{at}uku.fi

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
A BRCA2 Mutation, 4088insA, in a Finnish Breast and Ovarian Cancer Family Associated with Favourable Clinical Course
JAANA M. HARTIKAINEN, ARTO MANNERMAA, SEPPO HEINONEN, VELI-MATTI KOSMA, VESA KATAJA
Anticancer Research Nov 2007, 27 (6C) 4295-4300;
Twitter logo Facebook logo Mendeley logo

Jump to section